243 related articles for article (PubMed ID: 31433902)
1. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
Schröeder SE; Pedrana A; Scott N; Wilson D; Kuschel C; Aufegger L; Atun R; Baptista-Leite R; Butsashvili M; El-Sayed M; Getahun A; Hamid S; Hammad R; 't Hoen E; Hutchinson SJ; Lazarus JV; Lesi O; Li W; Binti Mohamed R; Olafsson S; Peck R; Sohn AH; Sonderup M; Spearman CW; Swan T; Thursz M; Walker T; Hellard M; Howell J
Liver Int; 2019 Oct; 39(10):1818-1836. PubMed ID: 31433902
[TBL] [Abstract][Full Text] [Related]
2. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.
Shiferaw F; Letebo M; Bane A
BMC Public Health; 2016 Aug; 16(1):769. PubMed ID: 27514515
[TBL] [Abstract][Full Text] [Related]
3. Global hepatitis C elimination: an investment framework.
Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
[TBL] [Abstract][Full Text] [Related]
4. The Elimination of Hepatitis C as a Public Health Threat.
Hellard M; Schroeder SE; Pedrana A; Doyle J; Aitken C
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31712223
[TBL] [Abstract][Full Text] [Related]
5. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
[TBL] [Abstract][Full Text] [Related]
6. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
Cooke GS; Andrieux-Meyer I; Applegate TL; Atun R; Burry JR; Cheinquer H; Dusheiko G; Feld JJ; Gore C; Griswold MG; Hamid S; Hellard ME; Hou J; Howell J; Jia J; Kravchenko N; Lazarus JV; Lemoine M; Lesi OA; Maistat L; McMahon BJ; Razavi H; Roberts T; Simmons B; Sonderup MW; Spearman CW; Taylor BE; Thomas DL; Waked I; Ward JW; Wiktor SZ;
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):135-184. PubMed ID: 30647010
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
[TBL] [Abstract][Full Text] [Related]
8. Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.
Papatheodoridis G; Thomas HC; Golna C; Bernardi M; Carballo M; Cornberg M; Dalekos G; Degertekin B; Dourakis S; Flisiak R; Goldberg D; Gore C; Goulis I; Hadziyannis S; Kalamitsis G; Kanavos P; Kautz A; Koskinas I; Leite BR; Malliori M; Manolakopoulos S; Matičič M; Papaevangelou V; Pirona A; Prati D; Raptopoulou-Gigi M; Reic T; Robaeys G; Schatz E; Souliotis K; Tountas Y; Wiktor S; Wilson D; Yfantopoulos J; Hatzakis A
J Viral Hepat; 2016 Feb; 23 Suppl 1():1-12. PubMed ID: 26809941
[TBL] [Abstract][Full Text] [Related]
9. A global investment framework for the elimination of hepatitis B.
Howell J; Pedrana A; Schroeder SE; Scott N; Aufegger L; Atun R; Baptista-Leite R; Hirnschall G; 't Hoen E; Hutchinson SJ; Lazarus JV; Olufunmilayo L; Peck R; Sharma M; Sohn AH; Thompson A; Thursz M; Wilson D; Hellard M
J Hepatol; 2021 Mar; 74(3):535-549. PubMed ID: 32971137
[TBL] [Abstract][Full Text] [Related]
10. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
[TBL] [Abstract][Full Text] [Related]
11. Research gaps in viral hepatitis.
Boyd A; Duchesne L; Lacombe K
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25054. PubMed ID: 29633564
[TBL] [Abstract][Full Text] [Related]
12. New WHO guidance for country validation of viral hepatitis B and C elimination.
Easterbrook P; Luhmann N; Newman M; Walsh N; Lesi O; Doherty M
Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):778-780. PubMed ID: 34384530
[No Abstract] [Full Text] [Related]
13. Progress towards elimination goals for viral hepatitis.
Cox AL; El-Sayed MH; Kao JH; Lazarus JV; Lemoine M; Lok AS; Zoulim F
Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):533-542. PubMed ID: 32704164
[TBL] [Abstract][Full Text] [Related]
14. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
15. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J;
Liver Int; 2019 Jan; 39(1):20-30. PubMed ID: 30157316
[TBL] [Abstract][Full Text] [Related]
17. Polaris Observatory-supporting informed decision-making at the national, regional, and global levels to eliminate viral hepatitis.
Razavi H
Antivir Ther; 2022 Apr; 27(2):13596535221083179. PubMed ID: 35499176
[No Abstract] [Full Text] [Related]
18. How far is Mexico from Viral Hepatitis Global Health Sector Strategy 2030 targets.
García-Sepúlveda CA; Laguna-Meraz S; Panduro A
Ann Hepatol; 2020; 19(2):123-125. PubMed ID: 32138870
[TBL] [Abstract][Full Text] [Related]
19. WORLD HEPATITIS SUMMIT HARNESSES GLOBAL MOMENTUM TO ELIMINATE VIRAL HEPATITIS.
Cent Eur J Public Health; 2015 Sep; 23(3):272. PubMed ID: 26618210
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
